阿曼塔丁对严重创伤性脑损伤后急性认知障碍的影响:一项机构试点研究
Brett M Tracy1, Shruthi Srinivas2, Kelly D Nahum3
1Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Surgery
|November 19, 2023
概括
在急性住院期间,阿曼塔丁可以改善严重创伤性脑损伤患者的认知障碍. 这项试点研究表明,阿曼塔丁的使用与更好的结果和康复出院有关.
科学领域:
- 神经科学是一个神经科学.
- 创伤护理 创伤护理
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿曼塔丁被确立为创伤性脑损伤 (TBI) 后的后急性认知改善.
- 它在TBI急性阶段的有效性仍然在很大程度上未经检查.
- 这项研究调查了阿曼塔丁在TBI早期恢复中的作用.
研究的目的:
- 评估阿曼塔丁对严重TBI患者短期认知障碍的影响.
- 假设阿曼塔丁的使用可以改善急性住院期间的残疾.
主要方法:
- 对严重TBI患者进行前性观察试点研究 (格拉斯哥昏迷表 ≤8).
- 排除标准包括透性创伤,早期死亡率和缺乏内病理.
- 通过残疾评分表 (DRS) 测量认知障碍在住院期间的变化.
主要成果:
- 阿曼塔丁组 (n=23) 在DRS得分上显著改善 (7.8比3.6,P=.001).
- 阿曼塔丁独立预测了DRS得分的改善 (β=1.61,P=.03).
- 在阿曼塔丁组中观察到更高的TBI康复出院率 (73.9%对21.9%,P=.0002).
结论:
- 在严重TBI的急性阶段使用阿曼塔丁可能会改善认知障碍.
- 早期使用阿曼塔丁与更快的康复和出院到专业康复相关.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
128
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
128
Amnesia
128
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
128
Alzheimer's Disease: Treatment
196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196


